PharmaCyte Biotech Inc (PMCB)

[JDT188]

Here's a thought. This company has only picked up steam over the past year or so. They are carefully mapping out in the right direction. So, once the trial data is released it will either be sink or swim. Either the pps will be through the roof or not. Yes we all know it is speculative. It's down 60% because they have not generated anything "substantial", or tangible, over the past year but they sure as hell are building a solid foundation for what could be monumental over the next several months. Too everyone else that is impatient, chillax!